Allison Fiscalini

Title(s)Director, Athena Breast Prog., Surgery
SchoolSchool of Medicine
Address550 16th Street, #6301
San Francisco CA 94158
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Santa Clara University, Santa Clara, CABS6/2005Psychology, Psychobiology
    University of Washington, Seattle, WAMPH6/2008Health Services, Social and Behavioral Sciences

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Extending the Diversity, Reach, and Generalizability of the WISDOM Study
    National Cancer Institute (NCI) 1R01CA237533-01A1Mar 1, 2020 - Feb 28, 2025
    Role: Project Director
    Description: Expansion of the WISDOM Study to new recruitment centers nationwide, focused on those that serve racial/ethnic minorities and have established community partnerships. The goal of this award is to increase the diversity of study enrollment by working with community partners and establishing partnerships with national organizations focused on diversity.
    Enabling a Paradigm Shift: A Preference-Tolerant RCT of Personalized vs. Annual Screening for Breast Cancer
    Patient Centered Outcomes Research Institute PCS-1402-10749Aug 1, 2015 - Oct 31, 2022
    Role: Project Director
    Description: Pragmatic RCT enrolling 100,000 healthy women to compare a novel, risk-based approach to breast cancer screening versus standard annual screening. The Athena Program Management office is the central coordinating center for the study and oversees all study activities, including study management platform, relationships with stakeholder, partners and vendors, and sponsor communications.

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Validation Study on Risk-Reduction Activities after Exposure to a Personalized Breast Cancer Risk-Assessment Education Tool in High-Risk Women in the WISDOM Study. Res Sq. 2023 May 10. Wang T, Che M, Huilgol YS, Keane H, Goodman D, Soonavala R, Ozanne E, Shieh Y, Belkora JK, Fiscalini AS, Athena Breast Health Network Investigators and Advocate Partners, Esserman LJ. PMID: 37214889; PMCID: PMC10197747.
      View in: PubMed   Mentions:
    2. Correction to: Social support as a moderator of healthcare adherence and distress in long-term hematopoietic cell transplantation survivors. J Cancer Surviv. 2022 Apr; 16(2):474-475. Nørskov KH, Yi JC, Crouch ML, Fiscalini AS, Flowers MED, Syrjala KL. PMID: 33826048.
      View in: PubMed   Mentions:    Fields:    
    3. The WISDOM study: a new approach to screening can and should be tested. Breast Cancer Res Treat. 2021 Oct; 189(3):593-598. Esserman L, Eklund M, Veer LV, Shieh Y, Tice J, Ziv E, Blanco A, Kaplan C, Hiatt R, Fiscalini AS, Yau C, Scheuner M, Naeim A, Wenger N, Lee V, Heditsian D, Brain S, Parker BA, LaCroix AZ, Madlensky L, Hogarth M, Borowsky A, Anton-Culver H, Kaster A, Olopade OI, Sheth D, Garcia A, Lancaster R, Plaza M. PMID: 34529196.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    4. Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry. NPJ Breast Cancer. 2021 Aug 03; 7(1):102. Huilgol YS, Keane H, Shieh Y, Hiatt RA, Tice JA, Madlensky L, Sabacan L, Fiscalini AS, Ziv E, Acerbi I, Che M, Anton-Culver H, Borowsky AD, Hunt S, Naeim A, Parker BA, van 't Veer LJ, Athena Breast Health Network Investigators and Advocate Partners, Esserman LJ. PMID: 34344894; PMCID: PMC8333106.
      View in: PubMed   Mentions: 3  
    5. Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial. NPJ Breast Cancer. 2021 Jun 17; 7(1):78. Keane H, Huilgol YS, Shieh Y, Tice JA, Belkora J, Sepucha K, Shibley WP, Wang T, Che M, Goodman D, Ozanne E, Fiscalini AS, Esserman LJ. PMID: 34140528; PMCID: PMC8211836.
      View in: PubMed   Mentions: 12  
    6. Social support as a moderator of healthcare adherence and distress in long-term hematopoietic cell transplantation survivors. J Cancer Surviv. 2021 12; 15(6):866-875. Nørskov KH, Yi JC, Crouch ML, Fiscalini AS, Flowers MED, Syrjala KL. PMID: 33420905; PMCID: PMC8267051.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    7. Response to Carter et al. JNCI Cancer Spectr. 2020 Apr; 4(2):pkaa016. Eklund M, Broglio K, Yau C, Connor JT, Fiscalini AS, Esserman LJ. PMID: 32373780; PMCID: PMC7192025.
      View in: PubMed   Mentions:    Fields:    
    8. Engagement with INSPIRE, an Online Program for Hematopoietic Cell Transplantation Survivors. Biol Blood Marrow Transplant. 2018 08; 24(8):1692-1698. Syrjala KL, Crouch ML, Leisenring WM, Flowers MED, Artherholt SB, Fiscalini AS, Romano E, Romano JM, Martin PJ, Yi JC. PMID: 29753161; PMCID: PMC6370551.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    9. An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation. J Cancer Surviv. 2018 08; 12(4):560-570. Syrjala KL, Yi JC, Artherholt SB, Romano JM, Crouch ML, Fiscalini AS, Hegel MT, Flowers MED, Martin PJ, Leisenring WM. PMID: 29730827; PMCID: PMC6054554.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    10. Total skin-sparing mastectomy and immediate breast reconstruction: an evolution of technique and assessment of outcomes. Ann Surg Oncol. 2014 Oct; 21(10):3223-30. Wang F, Peled AW, Garwood E, Fiscalini AS, Sbitany H, Foster RD, Alvarado M, Ewing C, Hwang ES, Esserman LJ. PMID: 25052246.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    11. Patient-reported outcomes and satisfaction after total skin-sparing mastectomy and immediate expander-implant reconstruction. Ann Plast Surg. 2014 May; 72 Suppl 1:S48-52. Peled AW, Duralde E, Foster RD, Fiscalini AS, Esserman LJ, Hwang ES, Sbitany H. PMID: 24317238.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    Allison's Networks
    Concepts (48)
    Derived automatically from this person's publications.
    Co-Authors (21)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department